Sillakivi T et al. |
An attempt at Helicobacter pylori eradication with intravenous clarithromycin in perforated peptic ulcer patients. |
2001 |
Scand. J. Gastroenterol. |
pmid:11589389
|
Tulassay Z et al. |
Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers. |
2010 |
Scand. J. Gastroenterol. |
pmid:20509752
|
Marignani M et al. |
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. |
1997 |
Scand. J. Gastroenterol. |
pmid:9200297
|
Valooran GJ et al. |
Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure. |
2011 |
Scand. J. Gastroenterol. |
pmid:21627398
|
Kajihara Y et al. |
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. |
2017 |
Scand. J. Gastroenterol. |
pmid:27806639
|
Ogura K et al. |
Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given? |
2001 |
Scand. J. Gastroenterol. |
pmid:11424316
|
Hojo M et al. |
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection. |
2001 |
Scand. J. Gastroenterol. |
pmid:11444467
|
Giorgio F et al. |
Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. |
2016 |
Scand. J. Gastroenterol. |
pmid:27687850
|
Ashorn M et al. |
Helicobacter pylori and iron deficiency anaemia in children. |
2001 |
Scand. J. Gastroenterol. |
pmid:11444468
|
Masuda H et al. |
Necessity of multiple gastric biopsies from different sites for detection of clarithromycin-resistant Helicobacter pylori strains. |
2003 |
Scand. J. Gastroenterol. |
pmid:14531530
|
Ellenrieder V et al. |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. |
1999 |
Scand. J. Gastroenterol. |
pmid:10499474
|
Ochi M et al. |
Regression of primary low-grade mucosa-associated lymphoid tissue lymphoma of duodenum after long-term treatment with clarithromycin. |
2006 |
Scand. J. Gastroenterol. |
pmid:16497629
|
Unge P et al. |
Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features? |
2003 |
Scand. J. Gastroenterol. |
pmid:12795457
|
de Boer WA and Tytgat GN |
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? |
1995 |
Scand. J. Gastroenterol. |
pmid:7638563
|
Seppälä K et al. |
Cure of Helicobacter pylori infection in all compliant patients: report on 644 subjects. |
2008 |
Scand. J. Gastroenterol. |
pmid:18609180
|
Befrits R et al. |
Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study. |
2004 |
Scand. J. Gastroenterol. |
pmid:15545163
|
Khan Z et al. |
Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study. |
2002 |
Scand. J. Gastroenterol. |
pmid:11843048
|
Gasbarrini A et al. |
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. |
2000 |
Scand. J. Gastroenterol. |
pmid:10766318
|
Fiorini G et al. |
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016. |
2018 |
Scand. J. Gastroenterol. |
pmid:29688095
|
Zevit N et al. |
Antibiotic resistance of Helicobacter pylori in Israeli children. |
2010 |
Scand. J. Gastroenterol. |
pmid:20199338
|
Abut E et al. |
Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study. |
2010 |
Scand. J. Gastroenterol. |
pmid:20334478
|
Pedrazzoli J et al. |
Transfer of clarithromycin to gastric juice is enhanced by omeprazole in Helicobacter pylori-infected individuals. |
2001 |
Scand. J. Gastroenterol. |
pmid:11761012
|
Li H et al. |
Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study. |
2018 |
Scand. J. Gastroenterol. |
pmid:29214879
|
Lindsetmo RO et al. |
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy. |
1998 |
Scand. J. Gastroenterol. |
pmid:9548613
|
Raymond J et al. |
Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools. |
2016 |
Scand. J. Gastroenterol. |
pmid:26784882
|
Lerang F et al. |
Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. |
1997 |
Scand. J. Gastroenterol. |
pmid:9438318
|
Seppälä K et al. |
Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients. |
2000 |
Scand. J. Gastroenterol. |
pmid:11063151
|
Higashida A et al. |
Effectiveness of esomeprazole-based triple therapy of H. pylori in young patients in Japan. |
2013 |
Scand. J. Gastroenterol. |
pmid:23016956
|
Testoni PA and Bagnolo F |
In dyspeptic patients without gastric phase III of the migrating motor complex, Helicobacter pylori eradication produces no short-term changes in interdigestive motility pattern. |
2000 |
Scand. J. Gastroenterol. |
pmid:10994618
|
Di Giulio M et al. |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. |
2016 |
Scand. J. Gastroenterol. |
pmid:26554617
|
Lee JW et al. |
A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea. |
2014 |
Scand. J. Gastroenterol. |
pmid:24988873
|
Cellini L et al. |
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. |
2006 |
Scand. J. Gastroenterol. |
pmid:16497614
|
Lee JW et al. |
GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea. |
2014 |
Scand. J. Gastroenterol. |
pmid:24957849
|
Tepes B |
Comparison of two invasive diagnostic tests for Helicobacter pylori after antimicrobial therapy. |
2007 |
Scand. J. Gastroenterol. |
pmid:17354112
|
Gisbert JP et al. |
Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection. |
2013 |
Scand. J. Gastroenterol. |
pmid:23556551
|
Gisbert JP et al. |
Unhealed duodenal ulcers despite Helicobacter pylori eradication. |
1997 |
Scand. J. Gastroenterol. |
pmid:9246702
|
Parente F et al. |
Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study. |
1998 |
Scand. J. Gastroenterol. |
pmid:9648983
|
Apostolopoulos P et al. |
Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study. |
2016 |
Scand. J. Gastroenterol. |
pmid:26435055
|
Doorakkers E et al. |
Helicobacter pylori eradication in the Swedish population. |
|
Scand. J. Gastroenterol. |
pmid:28323552
|
Tsukada K et al. |
Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients. |
2002 |
Scand. J. Gastroenterol. |
pmid:12465723
|
Murakami K et al. |
Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study. |
2011 |
Scand. J. Gastroenterol. |
pmid:21073372
|
Ribaldone DG et al. |
Helicobacter pylori eradication: poor medical compliance from East to West of the world. |
2018 |
Scand. J. Gastroenterol. |
pmid:29383955
|
Farup PG et al. |
Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. |
2002 |
Scand. J. Gastroenterol. |
pmid:12523585
|
Götz JM et al. |
Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori. |
1995 |
Scand. J. Gastroenterol. Suppl. |
pmid:8578230
|
Williamson R et al. |
New options in Helicobacter pylori eradication: efficacy, resistance and synergy. |
1998 |
Scand. J. Gastroenterol. Suppl. |
pmid:9515751
|
Unge P |
Review of Helicobacter pylori eradication regimens. |
1996 |
Scand. J. Gastroenterol. Suppl. |
pmid:8722388
|
Bazzoli F |
Italian omeprazole triple therapy--a 1-week regimen. |
1996 |
Scand. J. Gastroenterol. Suppl. |
pmid:8722395
|
Alfakry H et al. |
Periodontopathogen- and host-derived immune response in acute coronary syndrome. |
2011 |
Scand. J. Immunol. |
pmid:21645027
|
Alfakry H et al. |
The association of serum neutrophil markers and acute coronary syndrome. |
2012 |
Scand. J. Immunol. |
pmid:22537345
|
Lõivukene K et al. |
Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia. |
2000 |
Scand. J. Infect. Dis. |
pmid:10716079
|